Low-Level Laser Therapy for Fibromyalgia: A Systematic Review and Meta-Analysis

Shu Wei Yeh, Chien Hsiung Hong, Ming Chieh Shih, Ka Wai Tam, Yao Hsien Huang, Yi Chun Kuan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

BACKGROUND: Fibromyalgia is a chronic disorder characterized by widespread pain and tenderness. Low-level laser therapy (LLLT), an emerging nonpharmacological treatment, has been used for relieving musculoskeletal or neuropathic pain. OBJECTIVE: The objective of this review and meta-analysis was to determine the efficacy of LLLT on patients with fibromyalgia. STUDY DESIGN: This study involved systematic review and quantitative meta-analysis of published randomized controlled trials (RCTs). SETTING: This study examined all RCTs evaluating the effect of LLLT on fibromyalgia. METHODS: We performed a systematic review and meta-analysis of RCTs evaluating the effect of LLLT on patients with fibromyalgia. PubMed, EMBASE, and the Cochrane Library were searched for articles published before August 2018. RCTs meeting our selection criteria were included. The methodological quality of the RCTs was evaluated according to the Cochrane risk-for-bias method. Review Manager version 5.3 was used to perform the meta-analysis. The primary outcomes were the total scores on the Fibromyalgia Impact Questionnaire (FIQ), pain severity, and number of tender points. The secondary outcomes were changes in fatigue, stiffness, anxiety, and depression. Standardized mean difference (SMD), 95% confidence intervals (CI), and P values were calculated for outcome analysis. RESULTS: We identified 9 RCTs that included 325 fibromyalgia patients undergoing LLLT or placebo laser treatment with or without an exercise program. The meta-analysis showed that patients receiving LLLT demonstrated significantly greater improvement in their FIQ scores (SMD: 1.16; 95% CI, 0.64-1.69), pain severity (SMD: 1.18; 95% CI, 0.82-1.54), number of tender points (SMD: 1.01; 95% CI, 0.49-1.52), fatigue (SMD: 1.4; 95% CI, 0.96-1.84), stiffness (SMD: 0.92; 95% CI, 0.36-1.48), depression (SMD: 1.46; 95% CI, 0.93-2.00), and anxiety (SMD: 1.46; 95% CI, 0.45-2.47) than those receiving placebo laser. Furthermore, when compared with the standardized exercise program alone, LLLT plus the standardized exercise program provided no extra advantage in the relief of symptoms. On the other hand, the results of the only RCT using combined LLLT/LED phototherapy showed significant improvement in most outcomes except for depression when compared to placebo. When compared with pure exercise therapy, combined LLLT/LED phototherapy plus exercise therapy had additional benefits in reducing the severity of pain, number of tender points, and fatigue. LIMITATIONS: There were some limitations in this review, mostly because of the low-to-middle methodological quality of the selected studies; for example, there was no clear allocation process and only patients were blinded in most studies. In addition, one study used per-protocol analysis with a 20% loss to follow-up. On the other hand, the differences in laser types, energy sources, exposure times, and associated medication status in these studies may have resulted in some heterogeneity. CONCLUSIONS: Our results provided the most up-to-date and relevant evidence regarding the effects of LLLT in fibromyalgia. LLLT is an effective, safe, and well-tolerated treatment for fibromyalgia. KEY WORDS: Low-level laser therapy, fibromyalgia, meta-analysis, FIQ, pain, tender points,exercise.

Original languageEnglish
Pages (from-to)241-254
Number of pages14
JournalPain Physician
Volume22
Issue number3
Publication statusPublished - May 1 2019

Fingerprint

Fibromyalgia
Meta-Analysis
Confidence Intervals
Randomized Controlled Trials
Pain
Exercise
Fatigue
Exercise Therapy
Lasers
Phototherapy
Placebos
Depression
Low-Level Light Therapy
Anxiety
Musculoskeletal Pain
Neuralgia
PubMed
Patient Selection
Libraries
Therapeutics

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Low-Level Laser Therapy for Fibromyalgia : A Systematic Review and Meta-Analysis. / Yeh, Shu Wei; Hong, Chien Hsiung; Shih, Ming Chieh; Tam, Ka Wai; Huang, Yao Hsien; Kuan, Yi Chun.

In: Pain Physician, Vol. 22, No. 3, 01.05.2019, p. 241-254.

Research output: Contribution to journalArticle

Yeh, Shu Wei ; Hong, Chien Hsiung ; Shih, Ming Chieh ; Tam, Ka Wai ; Huang, Yao Hsien ; Kuan, Yi Chun. / Low-Level Laser Therapy for Fibromyalgia : A Systematic Review and Meta-Analysis. In: Pain Physician. 2019 ; Vol. 22, No. 3. pp. 241-254.
@article{cc31556e6c9e43ef87fb428ba1e86ccb,
title = "Low-Level Laser Therapy for Fibromyalgia: A Systematic Review and Meta-Analysis",
abstract = "BACKGROUND: Fibromyalgia is a chronic disorder characterized by widespread pain and tenderness. Low-level laser therapy (LLLT), an emerging nonpharmacological treatment, has been used for relieving musculoskeletal or neuropathic pain. OBJECTIVE: The objective of this review and meta-analysis was to determine the efficacy of LLLT on patients with fibromyalgia. STUDY DESIGN: This study involved systematic review and quantitative meta-analysis of published randomized controlled trials (RCTs). SETTING: This study examined all RCTs evaluating the effect of LLLT on fibromyalgia. METHODS: We performed a systematic review and meta-analysis of RCTs evaluating the effect of LLLT on patients with fibromyalgia. PubMed, EMBASE, and the Cochrane Library were searched for articles published before August 2018. RCTs meeting our selection criteria were included. The methodological quality of the RCTs was evaluated according to the Cochrane risk-for-bias method. Review Manager version 5.3 was used to perform the meta-analysis. The primary outcomes were the total scores on the Fibromyalgia Impact Questionnaire (FIQ), pain severity, and number of tender points. The secondary outcomes were changes in fatigue, stiffness, anxiety, and depression. Standardized mean difference (SMD), 95{\%} confidence intervals (CI), and P values were calculated for outcome analysis. RESULTS: We identified 9 RCTs that included 325 fibromyalgia patients undergoing LLLT or placebo laser treatment with or without an exercise program. The meta-analysis showed that patients receiving LLLT demonstrated significantly greater improvement in their FIQ scores (SMD: 1.16; 95{\%} CI, 0.64-1.69), pain severity (SMD: 1.18; 95{\%} CI, 0.82-1.54), number of tender points (SMD: 1.01; 95{\%} CI, 0.49-1.52), fatigue (SMD: 1.4; 95{\%} CI, 0.96-1.84), stiffness (SMD: 0.92; 95{\%} CI, 0.36-1.48), depression (SMD: 1.46; 95{\%} CI, 0.93-2.00), and anxiety (SMD: 1.46; 95{\%} CI, 0.45-2.47) than those receiving placebo laser. Furthermore, when compared with the standardized exercise program alone, LLLT plus the standardized exercise program provided no extra advantage in the relief of symptoms. On the other hand, the results of the only RCT using combined LLLT/LED phototherapy showed significant improvement in most outcomes except for depression when compared to placebo. When compared with pure exercise therapy, combined LLLT/LED phototherapy plus exercise therapy had additional benefits in reducing the severity of pain, number of tender points, and fatigue. LIMITATIONS: There were some limitations in this review, mostly because of the low-to-middle methodological quality of the selected studies; for example, there was no clear allocation process and only patients were blinded in most studies. In addition, one study used per-protocol analysis with a 20{\%} loss to follow-up. On the other hand, the differences in laser types, energy sources, exposure times, and associated medication status in these studies may have resulted in some heterogeneity. CONCLUSIONS: Our results provided the most up-to-date and relevant evidence regarding the effects of LLLT in fibromyalgia. LLLT is an effective, safe, and well-tolerated treatment for fibromyalgia. KEY WORDS: Low-level laser therapy, fibromyalgia, meta-analysis, FIQ, pain, tender points,exercise.",
author = "Yeh, {Shu Wei} and Hong, {Chien Hsiung} and Shih, {Ming Chieh} and Tam, {Ka Wai} and Huang, {Yao Hsien} and Kuan, {Yi Chun}",
year = "2019",
month = "5",
day = "1",
language = "English",
volume = "22",
pages = "241--254",
journal = "Pain Physician",
issn = "1533-3159",
publisher = "Association of Pain Management Anesthesiologists",
number = "3",

}

TY - JOUR

T1 - Low-Level Laser Therapy for Fibromyalgia

T2 - A Systematic Review and Meta-Analysis

AU - Yeh, Shu Wei

AU - Hong, Chien Hsiung

AU - Shih, Ming Chieh

AU - Tam, Ka Wai

AU - Huang, Yao Hsien

AU - Kuan, Yi Chun

PY - 2019/5/1

Y1 - 2019/5/1

N2 - BACKGROUND: Fibromyalgia is a chronic disorder characterized by widespread pain and tenderness. Low-level laser therapy (LLLT), an emerging nonpharmacological treatment, has been used for relieving musculoskeletal or neuropathic pain. OBJECTIVE: The objective of this review and meta-analysis was to determine the efficacy of LLLT on patients with fibromyalgia. STUDY DESIGN: This study involved systematic review and quantitative meta-analysis of published randomized controlled trials (RCTs). SETTING: This study examined all RCTs evaluating the effect of LLLT on fibromyalgia. METHODS: We performed a systematic review and meta-analysis of RCTs evaluating the effect of LLLT on patients with fibromyalgia. PubMed, EMBASE, and the Cochrane Library were searched for articles published before August 2018. RCTs meeting our selection criteria were included. The methodological quality of the RCTs was evaluated according to the Cochrane risk-for-bias method. Review Manager version 5.3 was used to perform the meta-analysis. The primary outcomes were the total scores on the Fibromyalgia Impact Questionnaire (FIQ), pain severity, and number of tender points. The secondary outcomes were changes in fatigue, stiffness, anxiety, and depression. Standardized mean difference (SMD), 95% confidence intervals (CI), and P values were calculated for outcome analysis. RESULTS: We identified 9 RCTs that included 325 fibromyalgia patients undergoing LLLT or placebo laser treatment with or without an exercise program. The meta-analysis showed that patients receiving LLLT demonstrated significantly greater improvement in their FIQ scores (SMD: 1.16; 95% CI, 0.64-1.69), pain severity (SMD: 1.18; 95% CI, 0.82-1.54), number of tender points (SMD: 1.01; 95% CI, 0.49-1.52), fatigue (SMD: 1.4; 95% CI, 0.96-1.84), stiffness (SMD: 0.92; 95% CI, 0.36-1.48), depression (SMD: 1.46; 95% CI, 0.93-2.00), and anxiety (SMD: 1.46; 95% CI, 0.45-2.47) than those receiving placebo laser. Furthermore, when compared with the standardized exercise program alone, LLLT plus the standardized exercise program provided no extra advantage in the relief of symptoms. On the other hand, the results of the only RCT using combined LLLT/LED phototherapy showed significant improvement in most outcomes except for depression when compared to placebo. When compared with pure exercise therapy, combined LLLT/LED phototherapy plus exercise therapy had additional benefits in reducing the severity of pain, number of tender points, and fatigue. LIMITATIONS: There were some limitations in this review, mostly because of the low-to-middle methodological quality of the selected studies; for example, there was no clear allocation process and only patients were blinded in most studies. In addition, one study used per-protocol analysis with a 20% loss to follow-up. On the other hand, the differences in laser types, energy sources, exposure times, and associated medication status in these studies may have resulted in some heterogeneity. CONCLUSIONS: Our results provided the most up-to-date and relevant evidence regarding the effects of LLLT in fibromyalgia. LLLT is an effective, safe, and well-tolerated treatment for fibromyalgia. KEY WORDS: Low-level laser therapy, fibromyalgia, meta-analysis, FIQ, pain, tender points,exercise.

AB - BACKGROUND: Fibromyalgia is a chronic disorder characterized by widespread pain and tenderness. Low-level laser therapy (LLLT), an emerging nonpharmacological treatment, has been used for relieving musculoskeletal or neuropathic pain. OBJECTIVE: The objective of this review and meta-analysis was to determine the efficacy of LLLT on patients with fibromyalgia. STUDY DESIGN: This study involved systematic review and quantitative meta-analysis of published randomized controlled trials (RCTs). SETTING: This study examined all RCTs evaluating the effect of LLLT on fibromyalgia. METHODS: We performed a systematic review and meta-analysis of RCTs evaluating the effect of LLLT on patients with fibromyalgia. PubMed, EMBASE, and the Cochrane Library were searched for articles published before August 2018. RCTs meeting our selection criteria were included. The methodological quality of the RCTs was evaluated according to the Cochrane risk-for-bias method. Review Manager version 5.3 was used to perform the meta-analysis. The primary outcomes were the total scores on the Fibromyalgia Impact Questionnaire (FIQ), pain severity, and number of tender points. The secondary outcomes were changes in fatigue, stiffness, anxiety, and depression. Standardized mean difference (SMD), 95% confidence intervals (CI), and P values were calculated for outcome analysis. RESULTS: We identified 9 RCTs that included 325 fibromyalgia patients undergoing LLLT or placebo laser treatment with or without an exercise program. The meta-analysis showed that patients receiving LLLT demonstrated significantly greater improvement in their FIQ scores (SMD: 1.16; 95% CI, 0.64-1.69), pain severity (SMD: 1.18; 95% CI, 0.82-1.54), number of tender points (SMD: 1.01; 95% CI, 0.49-1.52), fatigue (SMD: 1.4; 95% CI, 0.96-1.84), stiffness (SMD: 0.92; 95% CI, 0.36-1.48), depression (SMD: 1.46; 95% CI, 0.93-2.00), and anxiety (SMD: 1.46; 95% CI, 0.45-2.47) than those receiving placebo laser. Furthermore, when compared with the standardized exercise program alone, LLLT plus the standardized exercise program provided no extra advantage in the relief of symptoms. On the other hand, the results of the only RCT using combined LLLT/LED phototherapy showed significant improvement in most outcomes except for depression when compared to placebo. When compared with pure exercise therapy, combined LLLT/LED phototherapy plus exercise therapy had additional benefits in reducing the severity of pain, number of tender points, and fatigue. LIMITATIONS: There were some limitations in this review, mostly because of the low-to-middle methodological quality of the selected studies; for example, there was no clear allocation process and only patients were blinded in most studies. In addition, one study used per-protocol analysis with a 20% loss to follow-up. On the other hand, the differences in laser types, energy sources, exposure times, and associated medication status in these studies may have resulted in some heterogeneity. CONCLUSIONS: Our results provided the most up-to-date and relevant evidence regarding the effects of LLLT in fibromyalgia. LLLT is an effective, safe, and well-tolerated treatment for fibromyalgia. KEY WORDS: Low-level laser therapy, fibromyalgia, meta-analysis, FIQ, pain, tender points,exercise.

UR - http://www.scopus.com/inward/record.url?scp=85066951134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066951134&partnerID=8YFLogxK

M3 - Article

C2 - 31151332

AN - SCOPUS:85066951134

VL - 22

SP - 241

EP - 254

JO - Pain Physician

JF - Pain Physician

SN - 1533-3159

IS - 3

ER -